Emmanuel André Selected Research

Emmanuel André Research Topics

5	COVID-19 05/2022 - 11/2020
3	Tuberculosis (Tuberculoses) 03/2022 - 08/2018
3	Infections 01/2022 - 01/2018
1	Reinfection 01/2022
1	Fever (Fevers) 12/2019
1	Weight Loss (Weight Reduction) 12/2019
1	Multiple Organ Failure (MODS) 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 12/2018
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 08/2017

4	AntibodiesIBA 05/2022 - 11/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 11/2020
1	GoldIBA 03/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	AntigensIBA 01/2021
1	NucleoproteinsIBA 11/2020
1	SARS-CoV-2 spike proteinIBA 11/2020
1	Coloring Agents (Dyes)IBA 12/2019
1	AcidsIBA 12/2019
1	resazurinIBA 01/2019
1	Nitrate ReductaseIBA 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 12/2018
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 12/2018
1	Complement System Proteins (Complement)IBA 08/2018
1	Viral ProteinsIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	bedaquiline (R207910)IBA 08/2017

1	Home Nursing (Nursing, Home) 01/2022